Technical Analysis for GUD - Knight Therapeutics Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 5.870 | -0.84% | -0.050 |
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| BB Squeeze + Upper Band Touch | Range Contraction | 0.00% | |
| BB Squeeze Started | Range Contraction | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| New 52 Week Closing High | Bullish | -0.84% | |
| Doji - Bearish? | Reversal | -0.84% | |
| Stochastic Reached Overbought | Strength | -0.84% | |
| Overbought Stochastic | Strength | -0.84% | |
| Up 3 Days in a Row | Strength | -0.84% |
| Alert | Time |
|---|---|
| Down 1% | about 7 hours ago |
| Upper Bollinger Band Resistance | about 8 hours ago |
| New 52 Week High | about 8 hours ago |
| Rose Above Upper Bollinger Band | about 8 hours ago |
| Down 1% | 1 day ago |
Get a Trading Assistant
- Earnings date: 2024-05-09
Knight Therapeutics Inc. Description
Knight Therapeutics Inc is a Canada-based pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products, consumer health products and medical devices in Canada and select international markets. It finances other life sciences companies in Canada and internationally. Its prescription pharmaceuticals and medical devices in various stages of development include Impavido, AzaSite, ATryn, Photofrin, ILUVIEN, TULSA-PRO, PROBUPHINE, Advaxis Family of Products, Ember Family of Products, NeurAxon Family of Products, Antibe Family of Products, Blood Factor Products and VEWS Vascular Early Warning System. In addition, the Company also has a portfolio of branded consumer health products, including Neuragen, Flat Tummy Tea, FOCUSFactor, FLEXISEQ, SEQuaderma, HandMD, UrgentRx, Laboratoire Dr. Renaud, Premiology and Pro-Derm.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Marketing Pharma Pharmaceutical Labor Science Life Sciences Pharmaceuticals Pharmaceutical Products Pharmaceutical Industry Medical Devices Pharmaceutical Sciences Consumer Health Products Pharmaceutical Industry In China
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.95 |
| 52 Week Low | 4.35 |
| Average Volume | 69,003 |
| 200-Day Moving Average | 5.123 |
| 50-Day Moving Average | 5.553 |
| 20-Day Moving Average | 5.795 |
| 10-Day Moving Average | 5.799 |
| Average True Range | 0.129 |
| RSI (14) | 60.47 |
| ADX | 23.95 |
| +DI | 26.079 |
| -DI | 14.253 |
| Chandelier Exit (Long, 3 ATRs) | 5.564 |
| Chandelier Exit (Short, 3 ATRs) | 5.766 |
| Upper Bollinger Bands | 5.925 |
| Lower Bollinger Band | 5.664 |
| Percent B (%b) | 0.79 |
| BandWidth | 4.497 |
| MACD Line | 0.091 |
| MACD Signal Line | 0.088 |
| MACD Histogram | 0.0032 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.020 | ||||
| Resistance 3 (R3) | 6.030 | 5.990 | 5.995 | ||
| Resistance 2 (R2) | 5.990 | 5.952 | 5.985 | 5.987 | |
| Resistance 1 (R1) | 5.930 | 5.928 | 5.910 | 5.920 | 5.978 |
| Pivot Point | 5.890 | 5.890 | 5.880 | 5.885 | 5.890 |
| Support 1 (S1) | 5.830 | 5.852 | 5.810 | 5.820 | 5.762 |
| Support 2 (S2) | 5.790 | 5.828 | 5.785 | 5.753 | |
| Support 3 (S3) | 5.730 | 5.790 | 5.745 | ||
| Support 4 (S4) | 5.720 |
